Diagnostic Imaging Centers of Texas Expands VoxNeuro Collaboration to Enhance Post-Trauma Patient Evaluation Diagnostic Imaging Centers of Texas (DICOT) has announced an expanded collaboration with VoxNeuro Inc. designed to support a more integrated approach to evaluating patients recovering from motor…
Kerecis Launches Compact Fish-Skin Platform to Improve Deep Wound Management and Reduce Graft Waste Kerecis, a company focused on tissue regeneration using sustainably sourced fish skin, has announced the launch of Compact, a new fish-skin graft platform designed to address…
Lōkahi Therapeutics Expands ai2 Pipeline Program Through Partnership With Pepperdine E2B Lōkahi Therapeutics™, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), has announced a new collaboration with Pepperdine E2B™ (Education to Business) designed to connect graduate-level business education with real-world opportunities…
New Data Shows Breast Cancer Index Testing Influences Extended Endocrine Therapy Decisions Hologic, Inc. and its subsidiary Biotheranostics, Inc. have announced new findings from the Breast Cancer Index (BCI) Registry Study, showing that use of the genomic test resulted in…
THE SAGE GROUP Raises PAD Awareness During National PAD Awareness Month Peripheral artery disease (PAD) continues to be underrecognized and undertreated despite its substantial impact on limb health, cardiovascular outcomes and mortality, according to Mary L. Yost, president of THE…
Polaris Rx Selected Again as Exclusive U.S. Distributor for FluMist Home for 2026–2027 Flu Season Polaris Rx, a provider of long-term care, specialty and infusion pharmacy solutions, has been selected for a second consecutive year as the exclusive U.S. distributor…
Corcept Therapeutics Names Justin Gunn President of Endocrinology Division as Sean Maduck Retires Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage biopharmaceutical company focused on developing and commercializing medicines that modulate the effects of the hormone cortisol, has announced a leadership…
NeuPath Health to Host 2026 Physician Forum Focused on Advances in Chronic and Musculoskeletal Pain Care NeuPath Health Inc. (TSXV: NPTH), a Canadian healthcare company operating one of the country’s largest networks of community-based, multidisciplinary medical facilities, will host its…
Pattern Bioscience Receives FDA Breakthrough Device Designation for Urine ID/AST Panel Pattern Bioscience, a company developing rapid diagnostic technologies for bacterial infections, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its investigational…
Roche Opens Innovation Center Boston to Expand Cardiovascular, Renal and Metabolism Research Roche (SIX: RO, ROP; OTCQX: RHHBY) has officially opened the Roche Genentech Innovation Center Boston, marking a significant expansion of the company’s research and development presence in the…
AbbVie Presents New VRAYLAR Data Highlighting Real-World Outcomes in Depression and Bipolar I Disorder AbbVie (NYSE: ABBV) has presented new data for VRAYLAR® (cariprazine) at Psych Congress 2026 in New Orleans, Louisiana, highlighting findings from prospective real-world observational studies in…
Lilly to Present New Cardiometabolic Data on Foundayo, Retatrutide and EloraTZP at EASD 2026 Eli Lilly and Company (NYSE: LLY), the manufacturer of Zepbound® (tirzepatide), Mounjaro® (tirzepatide) and Foundayo® (orforglipron), is set to present a broad range of new data…